Salehmohamed M R, Griffin M, Branigan T, Cuesta M, Thompson C J
Academic Department of Endocrinology, Beaumont Hospital/RCSI Medical School, Beaumont Road, Dublin 9, Co. Dublin, Ireland.
RCSI Medical School, Dublin, Ireland.
Ir J Med Sci. 2018 Feb;187(1):69-74. doi: 10.1007/s11845-017-1607-y. Epub 2017 May 4.
Patients taking corticosteroids for immune suppression are vulnerable to adrenal crisis during acute illness or if steroids are stopped abruptly. Although patients treated for adrenal failure in endocrine units are routinely provided with sick day guidelines, we wished to ascertain whether patients on immunosuppressive steroids are appropriately advised.
This study sets out to compare patient awareness of steroid sick day rules in endocrine and non-endocrine patients.
A short case history is presented to illustrate the clinical impact of adrenal crisis in a patient on immune suppression. Subsequently, we present the results of a 9-point questionnaire, devised to determine knowledge of steroid sick day rules, in two patient cohorts. In group 1, patients on immunosuppressive steroids were recruited from non-endocrine clinics to complete the questionnaire. In group 2, patients on replacement steroids were recruited from endocrine clinics.
Endocrine patients exhibited better steroid use awareness; they were more likely to double their steroid dose when ill (89 v/s 23%), to obtain parenteral steroid during vomiting (83 v/s 27%), or during surgery (87 v/s 30%), and were aware of the need to carry a MedicAlert bracelet or a steroid-aware card (82 v/s 21%), (p < 0.001 for all comparisons).
Endocrine patients exhibited a significantly greater knowledge of sick day rules. The data does highlight the lack of patient awareness of the precautions for steroid use in patients on immunosuppressive steroid therapy for non-endocrine conditions, and the case presentation illustrates the potential hazards of this lack of awareness.
接受皮质类固醇免疫抑制治疗的患者在急性疾病期间或突然停用类固醇时易发生肾上腺危象。尽管在内分泌科接受肾上腺功能不全治疗的患者会常规获得患病日指南,但我们希望确定接受免疫抑制类固醇治疗的患者是否得到了适当的建议。
本研究旨在比较内分泌科和非内分泌科患者对类固醇患病日规则的知晓情况。
呈现一个简短的病例史,以说明肾上腺危象对一名接受免疫抑制治疗患者的临床影响。随后,我们展示了一份9分问卷的结果,该问卷旨在确定两个患者队列中对类固醇患病日规则的了解情况。在第1组中,从非内分泌诊所招募接受免疫抑制类固醇治疗的患者来完成问卷。在第2组中,从内分泌诊所招募接受替代类固醇治疗的患者。
内分泌科患者对类固醇使用的知晓度更高;他们在生病时更有可能将类固醇剂量加倍(89%对23%),在呕吐时(83%对27%)或手术期间(87%对30%)更有可能获得胃肠外类固醇,并且知道需要佩戴医疗急救手环或类固醇知晓卡(82%对21%),(所有比较p<0.001)。
内分泌科患者对患病日规则的了解明显更多。数据确实凸显了接受非内分泌疾病免疫抑制类固醇治疗的患者对类固醇使用预防措施缺乏认识,而病例展示说明了这种认识不足的潜在危害。